Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Asymmetric ring structure of Vps4 required for ESCRT-III disassembly.

Caillat C, Macheboeuf P, Wu Y, McCarthy AA, Boeri-Erba E, Effantin G, Göttlinger HG, Weissenhorn W, Renesto P.

Nat Commun. 2015 Dec 3;6:8781. doi: 10.1038/ncomms9781.

2.

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Usami Y, Wu Y, Göttlinger HG.

Nature. 2015 Oct 8;526(7572):218-23. doi: 10.1038/nature15400. Epub 2015 Sep 30.

3.

The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Usami Y, Popov S, Göttlinger HG.

J Virol. 2014 Mar;88(6):3443-54. doi: 10.1128/JVI.01933-13. Epub 2014 Jan 8. Erratum in: J Virol. 2014 May;88(10):5900.

4.

UPF1 is crucial for the infectivity of human immunodeficiency virus type 1 progeny virions.

Serquiña AK, Das SR, Popova E, Ojelabi OA, Roy CK, Göttlinger HG.

J Virol. 2013 Aug;87(16):8853-61. doi: 10.1128/JVI.00925-13. Epub 2013 Jun 19.

5.

Structural basis of tetherin function.

Weissenhorn W, Miguet N, Aschman N, Renesto P, Usami Y, Gottlinger HG.

Curr HIV Res. 2012 Jun;10(4):298-306. Review.

PMID:
22524178
6.

Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A.

Usami Y, Popov S, Weiss ER, Vriesema-Magnuson C, Calistri A, Göttlinger HG.

J Virol. 2012 Apr;86(7):3746-56. doi: 10.1128/JVI.06539-11. Epub 2012 Jan 18.

7.

Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.

Popov S, Strack B, Sanchez-Merino V, Popova E, Rosin H, Göttlinger HG.

J Virol. 2011 Apr;85(8):3792-801. doi: 10.1128/JVI.02329-10. Epub 2011 Feb 2.

8.

Influenza exits the cell without an ESCRT.

Göttlinger HG.

Cell. 2010 Sep 17;142(6):839-41. doi: 10.1016/j.cell.2010.08.036.

9.

Human immunodeficiency virus type 1 nucleocapsid p1 confers ESCRT pathway dependence.

Popova E, Popov S, Göttlinger HG.

J Virol. 2010 Jul;84(13):6590-7. doi: 10.1128/JVI.00035-10. Epub 2010 Apr 28.

10.

A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments.

Pires R, Hartlieb B, Signor L, Schoehn G, Lata S, Roessle M, Moriscot C, Popov S, Hinz A, Jamin M, Boyer V, Sadoul R, Forest E, Svergun DI, Göttlinger HG, Weissenhorn W.

Structure. 2009 Jun 10;17(6):843-56. doi: 10.1016/j.str.2009.04.007.

11.

Divergent Bro1 domains share the capacity to bind human immunodeficiency virus type 1 nucleocapsid and to enhance virus-like particle production.

Popov S, Popova E, Inoue M, Göttlinger HG.

J Virol. 2009 Jul;83(14):7185-93. doi: 10.1128/JVI.00198-09. Epub 2009 Apr 29.

12.

Structure and function of ESCRT-III.

Lata S, Schoehn G, Solomons J, Pires R, Göttlinger HG, Weissenhorn W.

Biochem Soc Trans. 2009 Feb;37(Pt 1):156-60. doi: 10.1042/BST0370156. Review.

PMID:
19143622
13.

Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

Pizzato M, Popova E, Göttlinger HG.

J Virol. 2008 Nov;82(21):10811-9. doi: 10.1128/JVI.01150-08. Epub 2008 Aug 20.

14.

Helical structures of ESCRT-III are disassembled by VPS4.

Lata S, Schoehn G, Jain A, Pires R, Piehler J, Gottlinger HG, Weissenhorn W.

Science. 2008 Sep 5;321(5894):1354-7. doi: 10.1126/science.1161070. Epub 2008 Aug 7.

15.

Structural basis for autoinhibition of ESCRT-III CHMP3.

Lata S, Roessle M, Solomons J, Jamin M, Gottlinger HG, Svergun DI, Weissenhorn W.

J Mol Biol. 2008 May 9;378(4):818-27. doi: 10.1016/j.jmb.2008.03.030. Epub 2008 Mar 20.

16.

Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase.

Usami Y, Popov S, Popova E, Göttlinger HG.

J Virol. 2008 May;82(10):4898-907. doi: 10.1128/JVI.02675-07. Epub 2008 Mar 5.

17.

HIV/AIDS: virus kept on a leash.

Göttlinger HG.

Nature. 2008 Jan 24;451(7177):406-8. doi: 10.1038/nature06364. No abstract available.

PMID:
18200012
18.

Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid.

Popov S, Popova E, Inoue M, Göttlinger HG.

J Virol. 2008 Feb;82(3):1389-98. Epub 2007 Nov 21.

19.
20.

Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.

Pizzato M, Helander A, Popova E, Calistri A, Zamborlini A, Palù G, Göttlinger HG.

Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6812-7. Epub 2007 Apr 5.

21.

How HIV-1 hijacks ALIX.

Göttlinger HG.

Nat Struct Mol Biol. 2007 Apr;14(4):254-6. No abstract available.

PMID:
17410087
22.

Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation.

Ma YM, Boucrot E, Villén J, Affar el B, Gygi SP, Göttlinger HG, Kirchhausen T.

J Biol Chem. 2007 Mar 30;282(13):9805-12. Epub 2007 Jan 29.

23.

AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.

Strack B, Calistri A, Craig S, Popova E, Göttlinger HG.

Cell. 2003 Sep 19;114(6):689-99.

24.

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism.

Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, Bieniasz PD.

Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11914-9. Epub 2002 Aug 1.

25.

Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix.

Dorfman T, Popova E, Pizzato M, Göttlinger HG.

J Virol. 2002 Jul;76(13):6857-62.

26.
27.

The HIV-1 assembly machine.

Göttlinger HG.

AIDS. 2001;15 Suppl 5:S13-20. Review. No abstract available.

PMID:
11816161
28.

Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.

Yang OO, Nguyen PT, Kalams SA, Dorfman T, Göttlinger HG, Stewart S, Chen IS, Threlkeld S, Walker BD.

J Virol. 2002 Feb;76(4):1626-31.

29.

A role for ubiquitin ligase recruitment in retrovirus release.

Strack B, Calistri A, Accola MA, Palu G, Gottlinger HG.

Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13063-8.

30.
34.
35.

Efficient HIV-1 replication can occur in the absence of the viral matrix protein.

Reil H, Bukovsky AA, Gelderblom HR, Göttlinger HG.

EMBO J. 1998 May 1;17(9):2699-708.

36.

Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.

Kobinger GP, Borsetti A, Nie Z, Mercier J, Daniel N, Göttlinger HG, Cohen A.

J Virol. 1998 Jul;72(7):5441-8.

38.
39.

Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions.

Dorfman T, Weimann A, Borsetti A, Walsh CT, Göttlinger HG.

J Virol. 1997 Sep;71(9):7110-3.

40.
41.

Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17.

Levin R, Mhashilkar AM, Dorfman T, Bukovsky A, Zani C, Bagley J, Hinkula J, Niedrig M, Albert J, Wahren B, Göttlinger HG, Marasco WA.

Mol Med. 1997 Feb;3(2):96-110.

42.

Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease.

Bukovsky AA, Dorfman T, Weimann A, Göttlinger HG.

J Virol. 1997 Feb;71(2):1013-8.

44.

Role of auxiliary proteins in retroviral morphogenesis.

Cohen EA, Subbramanian RA, Göttlinger HG.

Curr Top Microbiol Immunol. 1996;214:219-35. Review. No abstract available.

PMID:
8791729
46.

Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.

Checroune F, Yao XJ, Göttlinger HG, Bergeron D, Cohen EA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):1-7.

PMID:
7648278
47.

Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.

Mammano F, Kondo E, Sodroski J, Bukovsky A, Göttlinger HG.

J Virol. 1995 Jun;69(6):3824-30.

48.
49.

Functional domains of the capsid protein of human immunodeficiency virus type 1.

Dorfman T, Bukovsky A, Ohagen A, Höglund S, Göttlinger HG.

J Virol. 1994 Dec;68(12):8180-7.

50.

Functional association of cyclophilin A with HIV-1 virions.

Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, Göttlinger HG.

Nature. 1994 Nov 24;372(6504):363-5.

PMID:
7969495

Supplemental Content

Loading ...
Support Center